Meisoindigo is highly effective against gemcitabine-resistant PDAC.
Meisoindigo preferentially targets CSC population.
Meisoindigo interferes with cellular redox balance.
Meisoindigo activates AMPK cascade, but inhibits LKB1.
LKB1 knockdown mimics the effect of meisoindigo in CSCs.